Palogic Value Management’s Expensify EXFY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.17M Sell
1,768,456
-754,110
-30% -$846K 1.03% 20
2026
Q1
$2.19M Buy
2,522,566
+1,119,501
+80% +$1.33M 0.93% 26
2025
Q4
$2.12M Buy
1,403,065
+470,078
+50% +$745K 0.88% 31
2025
Q3
$1.73M Buy
932,987
+431,567
+86% +$874K 0.69% 40
2025
Q2
$1.3M Buy
501,420
+96,935
+24% +$248K 0.53% 54
2025
Q1
$1.23M Sell
404,485
-146,321
-27% -$508K 0.53% 64
2024
Q4
$1.85M Sell
550,806
-324,194
-37% -$872K 0.7% 46
2024
Q3
$1.72M Sell
875,000
-625,000
-42% -$1.3M 0.58% 49
2024
Q2
$2.23M Buy
1,500,000
+232,386
+18% +$366K 0.95% 31
2024
Q1
$2.33M Buy
1,267,614
+467,614
+58% +$888K 1.01% 31
2023
Q4
$1.98M Buy
800,000
+200,000
+33% +$518K 0.88% 39
2023
Q3
$1.95M Buy
+600,000
New +$3.24M 0.92% 34

Other funds holding EXFY

Palogic Value Management's EXFY Position: Q2 2026 in Review

Palogic Value Management reduced its Expensify (EXFY) stake by 30% in Q2 2026, selling an estimated $846K and leaving 1,768,456 shares worth $3.17M. The position accounts for 1.03% of the portfolio, ranked #20.

Palogic Value Management first reported a position in EXFY in Q3 2023 and has held it in 12 quarters since. 100 funds tracked by Wall St. Rank hold EXFY as of Q2 2026.

  • Palogic Value Management held 1,768,456 shares of Expensify worth $3.17M as of Q2 2026.
  • Palogic Value Management sold 754,110 Expensify shares in Q2 2026, an estimated $846K.
  • Expensify made up 1.03% of Palogic Value Management's portfolio in Q2 2026, its #20 holding.
  • Palogic Value Management first reported a position in Expensify in Q3 2023 and has held it in 12 quarters since.
  • 100 funds tracked by Wall St. Rank held Expensify as of Q2 2026.

Based on Palogic Value Management's 13F filing for Q2 2026, filed 14 Aug 2026.